Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF
Clinical trial NCT02579603 · COMPLETED
Trial details
- NCT number
- NCT02579603
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-16
- Primary completion
- 2017-01-03
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.